Biogen Inc (BIIB)

07:32 AM

Thrivent Financial for Lutherans Has $2.42 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

07:32 AM

12:54 PM

The US approved an Alzheimer’s drug. Seven patients subsequently died. - The Boston Globe

12:54 PM

07:34 AM

United Bank Sells 2,213 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

07:34 AM

05:41 AM

Level Four Advisory Services LLC Has $1.14 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

05:41 AM

05:01 AM

Norges Bank Buys New Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

05:01 AM

04:41 AM

Mitsubishi UFJ Trust & Banking Corp Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:41 AM

04:34 AM

UniSuper Management Pty Ltd Sells 42,345 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:34 AM

04:30 AM

Elo Mutual Pension Insurance Co Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:30 AM

04:28 AM

Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat

04:28 AM

Mar 30, 2025

Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up - MSN

Mar 30, 2025

Mar 30, 2025

Biogen (NASDAQ:BIIB) Shares Acquired Rep. Robert Bresnahan, Jr. - MarketBeat

Mar 30, 2025

Mar 30, 2025

Beutel Goodman & Co Ltd. Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 30, 2025

Mar 30, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by NEOS Investment Management LLC - MarketBeat

Mar 30, 2025

Mar 30, 2025

Vanguard Group Inc. Buys 70,368 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Virtu Financial LLC Decreases Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 29, 2025

Mar 29, 2025

Prudential Financial Inc. Acquires 152,992 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 29, 2025

Mar 29, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Sold by HighTower Advisors LLC - MarketBeat

Mar 29, 2025

Mar 28, 2025

Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint

Mar 28, 2025

Mar 28, 2025

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen - Benzinga

Mar 28, 2025

Mar 28, 2025

Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen - BioPharma Dive

Mar 28, 2025

Mar 28, 2025

Trend Tracker for (BIIB) - Stock Traders Daily

Mar 28, 2025

Mar 28, 2025

Mizuho Securities USA LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 28, 2025

Mar 28, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Teacher Retirement System of Texas - MarketBeat

Mar 28, 2025

Mar 27, 2025

Natixis Advisors LLC Reduces Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 27, 2025

Mar 27, 2025

Hillsdale Investment Management Inc. Buys Shares of 4,610 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 27, 2025

Mar 27, 2025

Biogen Inc. (NASDAQ:BIIB) Stock Holdings Trimmed by Northwest & Ethical Investments L.P. - MarketBeat

Mar 27, 2025

Mar 27, 2025

BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 27, 2025

Mar 27, 2025

Biogen: Balancing Risks And Opportunities - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Biogen plans new headquarters at Kendall Common - MSN

Mar 27, 2025

Mar 27, 2025

Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - The Motley Fool

Mar 27, 2025

Mar 27, 2025

Lilly adds Alzheimer's to online offerings - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

6,175 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Crowley Wealth Management Inc. - MarketBeat

Mar 27, 2025

Mar 27, 2025

Biogen to Move Global Headquarters to Kendall Commons in 2028 - The Harvard Crimson

Mar 27, 2025

Mar 26, 2025

1,874 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Vinva Investment Management Ltd - MarketBeat

Mar 26, 2025

Mar 25, 2025

Sector Gamma AS Sells 6,166 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 25, 2025

Mar 25, 2025

BIOGEN TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025 - Biogen

Mar 25, 2025

Mar 25, 2025

Roche Voids Biogen's Protein Production Patent At EPO - Law360

Mar 25, 2025

Mar 25, 2025

Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your RightsBIIB - ACCESS Newswire

Mar 25, 2025

Mar 25, 2025

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square - Boston Real Estate Times

Mar 25, 2025

Mar 25, 2025

Cassava Sciences shuts down Alzheimer's programshares plummet - Marketscreener.com

Mar 25, 2025

Mar 25, 2025

KLP Kapitalforvaltning AS Acquires Shares of 92,377 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 25, 2025

Mar 24, 2025

News | Blackstone’s BioMed adds biotech hub in Boston area with added demand - CoStar Group

Mar 24, 2025

Mar 24, 2025

7 Stocks Still Trading Below COVID Lows 5 Years Later - MSN

Mar 24, 2025

Mar 24, 2025

Biogen to Relocate Headquarters to New Development by MIT and BioMed - Connect CRE

Mar 24, 2025

Mar 24, 2025

Biogen to consolidate operations at new global headquarters in Cambridge - FirstWord Pharma

Mar 24, 2025

Mar 24, 2025

Biogen plots new global headquarters in Kendall Square - BioPharma Dive

Mar 24, 2025

Mar 24, 2025

Biogen Relocating to MIT Development in Cambridge - Banker & Tradesman

Mar 24, 2025

Mar 24, 2025

Biogen Signs Lease for New Global HQ in Cambridge, Massachusetts -March 24, 2025 at 09:37 am EDT - Marketscreener.com

Mar 24, 2025

Mar 24, 2025

Biogen Plans New Global Headquarters in Cambridge, Massachusetts -March 24, 2025 at 08:18 am EDT - Marketscreener.com

Mar 24, 2025

Mar 24, 2025

Biogen to establish new HQ in Cambridge by 2028 - Investing.com

Mar 24, 2025

Mar 24, 2025

Biogen Plans For State-of-the-Art Global Headquarters At Kendall Common, Set To Open In 2028 - Nasdaq

Mar 24, 2025

Mar 24, 2025

Biogen Announces Plans For New Global Headquarters And Innovation Hub In Kendall Square - Marketscreener.com

Mar 24, 2025